Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 161
Infectious Diseases Drugs 123
Genomics 100
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 52
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 37
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 25
Oncology 22
Pulmonary Medicine 20
Central Nervous System Drugs 20
Drug Delivery 19
Infusions and Injectables 17
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 12
Healthcare Services 10
Diagnostics 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Hematology 9
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Lung Cancer Drugs 6
Hepatology 5
Women's Health 5
Colon Cancer Drugs 5
Analgesics 5
Nanomedicine 5
Company Reports 4
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Needles and Syringes 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

1,018 Results (Page 25 of 51)
- Relevance
  Sort by

Basal Cell Carcinoma Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Lung Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Targeted Liposomes Drug Delivery Market - Global Strategic Business Report

 Report
October 2026
181 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

Liposome Drug Delivery Market - Global Strategic Business Report

 Report
October 2026
576 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

Pharmaceutical Drug Delivery Market - Global Strategic Business Report

 Report
October 2026
301 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cystic Fibrosis Therapeutics - Global Strategic Business Report

 Report
October 2026
282 Pages
Global

From

€5378EUR$5,850USD£4,572GBP

Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

 Report
November 2025
187 Pages
Global

From

€4137EUR$4,500USD£3,517GBP

Leukemia Targeted Therapy Drugs Market - Global Forecast 2026-2032

 Report
September 2026
187 Pages
Global

From

€3259EUR$3,545USD£2,771GBP

€3621EUR$3,939USD£3,079GBP

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
589 Pages
Global

From

€2298EUR$2,500USD£1,954GBP

T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Regional Outlook and Forecast, 2023 - 2030

 Report
June 2023
263 Pages
Global

From

€3309EUR$3,600USD£2,814GBP

Stem Cell Therapy Market - Global Forecast 2026-2032

 Report
September 2026
185 Pages
Global

From

€3259EUR$3,545USD£2,771GBP

€3621EUR$3,939USD£3,079GBP

Global TROP2 Antibody Market Opportunity & Clinical Trials Insight 2030

 Report
February 2025
200 Pages
Global

From

€2574EUR$2,800USD£2,188GBP

Hairy Cell Leukemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
185 Pages
Global

From

€4137EUR$4,500USD£3,517GBP

Myelodysplastic Syndrome Drug Market - Global Forecast 2026-2032

 Report
September 2026
193 Pages
Global

From

€3259EUR$3,545USD£2,771GBP

€3621EUR$3,939USD£3,079GBP

Global Antibiotics Market - Distribution by Type of Drug Class, Target Disease Indication, Type of Therapy (Monotherapies and Combination Therapies), Route of Administration and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
April 2023
175 Pages
Global

From

€5423EUR$5,899USD£4,610GBP

Leukemia Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Multiple Myeloma Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4127EUR$4,490USD£3,509GBP

Acute Lymphocytic Leukemia - Market Insight, Epidemiology, and Market Forecast - 2036

 Report
July 2026
257 Pages
Global

From

€7345EUR$7,990USD£6,245GBP

Autoimmune Collaboration and Licensing Deals 2016-2026

 Report
October 2026
550 Pages
Global

From

€3672EUR$3,995USD£3,122GBP

1,018 Results (Page 25 of 51)
- 1
- 23
- 24
- 25
- 26
- 27

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.